A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China

NCT06512337 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Deucravacitinib

Sponsor

Bristol-Myers Squibb